Market Reports

Multiplexed Diagnostics 2009 Market Report
Published March 2009

Multiplexed diagnostics are the long-awaited ascendance of ’omics into healthcare. The promise of multiple measurements to characterize complexity is finally being realized. More>>

Cancer Personalized Medicine 2008
Published July 2008

The Cancer Personalized Medicine marketplace represents the paradigm for personalized medicine market evolution and Select Biosciences focuses in this report on the various commercialized cancer predictor tests, their current status, traction in the marketplace, quantitative market opportunities, and the factors that are driving as well as challenging the expansion of this space. Personalized Medicine, especially as it relates to Cancer, is undergoing significant growth and this report focuses i More>>

Peptides 2006 - New Applications in Discovery, Manufacturing, and Therapeutics
Published Published June 2006

Peptides 2006 analyzes the current peptide market. It features an analysis of therapeutic peptide products in multiple disease indications, as well as an up to date overview of key patent issues in this space. More>>

Organic and Medicinal Chemistry in Drug Discovery
Published October 2005

D&MD's Organic and Medicinal Chemistry in Drug Discovery market analysis report investigates the methods and technologies currently used to craft compound collections as well as the products and services available to support pharmaceutical chemistry programs. More>>

Biomarkers and Related Tests for Molecular Diagnostics and Pharma/ Biotech R&D
Published July 2005

This report maps out the major areas of the market ecosystem for biomarkers and related tests. This insightful study shows that this market is big business and reached $7.1 billion in 2004. The study reveals that molecular diagnostic companies are poised for continued strong growth. The mix of pharma/ biotech companies doing biomarker related R&D is also beginning to show gains. More>>

Molecular Diagnostics 2005
Published spring 2005

This report analyzes the technologies and their impact in the molecular diagnostics marketplace. An assessment of all the technologies of value in this market and which market segments are impacted and affected by these technologies. More>>

Solving Drug Discovery with Metabolomics and Metabonomics
Published February 2005

There has been an 'omics' explosion. With the advent of genomics, proteomics, transcriptomics, there is also now metabolomics and metabonomics. These terms are the newest sibling to genomics and proteomics and are supposed to embody metabolic profiling. More>>

Antibodies in China
Published February 2005

The purpose of this report is to provide a comprehensive resource to companies, investors, and entrepreneurs interested either in accessing China's market for antibody products or cost effective production of antibodies for therapeutic, diagnostic, or laboratory use. More>>